Hormonal therapy for endometriosis: from molecular research to bedside.

@article{Tosti2017HormonalTF,
  title={Hormonal therapy for endometriosis: from molecular research to bedside.},
  author={Claudia Tosti and Antonella Biscione and Giuseppe Morgante and Giuseppe Bifulco and Stefano Vincenzo Luisi and Felice Petraglia},
  journal={European journal of obstetrics, gynecology, and reproductive biology},
  year={2017},
  volume={209},
  pages={
          61-66
        }
}
  • C. Tosti, A. Biscione, F. Petraglia
  • Published 1 February 2017
  • Medicine, Biology
  • European journal of obstetrics, gynecology, and reproductive biology
Hormonal treatments for endometriosis: The endocrine background
TLDR
This review aims to provide a comprehensive state-of-the-art on the current and future hormonal treatments for endometriosis, exploring the endocrine background of the disease.
CODEN: IJPNL6 MANAGEMENT OF ENDOMETRIOSIS: AN ENIGMATIC DISEASE
TLDR
The aim of this review article is to understand and study the new molecules and conventional treatment that are effective for the management of endometriosis associated pain.
Role of Aromatase Inhibitor in Endometriosis
TLDR
Aromatase inhibitors showed comparable efficacy with other medical therapeutic modalities with a slight edge in providing both symptomatic relief and fertility treatment in endometriosis.
Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis
TLDR
Animal models, human trials demonstrated progesterone (P4) and progestins influences over progression of disease pathological characteristics, associated to endometrial ER, PR aberrant expressions: ER α loss, and abnormal PRB/PRA ratio.
Use of dopamine agonists to target angiogenesis in women with endometriosis.
TLDR
The data support the use of DAs in the medical management of endometriosis to reduce lesion size and pain while maintaining ovulation and a combined approach ofDAs and pentoxifylline is perhaps a smart way of targeting the disease from a completely different angle than current medical treatments.
From pathogenesis to clinical practice: Emerging medical treatments for endometriosis.
Predictive Biomarkers May allow Precision Therapy of Endometriosis
TLDR
PR expression may predict progestin resistance in endometriosis while CYP19A1 expression may indicate the need to block estrogen signaling, piloted a personalized medicine approach.
Medical treatment of endometriosis-related pain.
Investigational drugs for the treatment of endometriosis, an update on recent developments
TLDR
This review aims to offer the reader a complete and updated overview on new investigational drugs and early molecular targets for the treatment of endometriosis and describes the pre-clinical and clinical development of these agents.
...
...

References

SHOWING 1-10 OF 89 REFERENCES
Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman
TLDR
Endometriosis is a chronic and progressive disease manifested by chronic pelvic pain and infertility and which may affect 2–10% of women of reproductive age and the goal of current medical therapy is to induce hypoestrogenism or to antagonise oestrogen action.
An update on the pharmacological management of endometriosis
TLDR
The medical treatment of endometriosis is effective at treating pain and preventing recurrence of disease after surgery, and the oral contraceptive pill taken continuously is as effective as GnRH-a, while causing far less side-effects.
Progesterone receptor modulators in gynaecological practice
TLDR
The development of progesterone receptor modulators (PRMSs) is discussed and the evidence for the use of the PRMs that have been administered in clinical trials to date is focused on.
New trends for the medical treatment of endometriosis
TLDR
The literature evidence of new medical treatments for endometriosis, defined as pharmacological treatments not yet commonly available and currently under investigation, are reviewed to systematically review the literature evidence.
Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium.
TLDR
LNG-IUS reduced both cell proliferation and the expression of PRA and ER-alpha and increased Fas expression in the eutopic and ectopic endometrium of patients with endometriosis.
Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis.
TLDR
REA modulates cross talk among multiple cell types in the uterine tissue and host background, serving as a brake on the estradiol-ER axis and restraining multiple aspects that contribute to the pathologic progression of endometriosis.
Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis
TLDR
Dienogest (DNG), a progestin of 19-nortestosterone derivative, has good oral bioavailability and is highly selective for progesterone receptors, and is expected to be an effective treatment for endometriosis.
Danazol for pelvic pain associated with endometriosis.
TLDR
Treatment with danazol was effective in relieving painful symptoms related to endometriosis when compared to placebo, however, its use is limited by the occurrence of androgenic side effects.
...
...